ArticleDiagnostics (Basel, Switzerland)2024

JAKinhibs in Psoriatic Disease: Analysis of the Efficacy/Safety Profile in Daily Clinical Practice.

Francesco Bizzarri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.